Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
12/2000
12/07/2000WO2000073269A2 Nicotine receptor ligands
12/07/2000WO2000073257A1 Derivatives of butyric acid and uses thereof
12/07/2000WO2000072834A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
12/07/2000WO2000072800A2 Il-8 receptor antagonists
12/07/2000WO2000009104A3 Use of sulfonamides for treating vision and memory disorders
12/06/2000EP1057815A1 Cyclic amide compounds
12/06/2000EP1056734A2 Substituted alxoxycarbonyl compounds
12/06/2000EP1056733A1 Histamine h3 receptor ligands
12/06/2000CN1275977A Heterocyclic thioesters and ketones
12/05/2000US6156900 Racemization of precursors to levobupivacaine and analogues thereof
12/05/2000US6156889 Reagent useful for cleaving a protected functional group
12/05/2000US6156770 Antiviral agents, bactericides, antitumor agents and antihistamines
12/05/2000US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
12/05/2000CA2188452C Guanidino-substituted compounds
11/2000
11/30/2000WO2000071572A1 Substituted beta-alanine derivatives as cell adhesion inhibitors
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071529A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000WO2000071519A2 Immunopotentiator agents
11/30/2000WO2000071518A2 Heterocyclic analgesic compounds and their use
11/30/2000WO2000071516A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071515A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071506A2 Naphthalene ureas as glucose uptake enhancers
11/30/2000WO2000071171A2 Sigma-1 ligands for determining carcinoma proliferative status
11/30/2000WO2000071124A1 Amorphous form of fexofenadine hydrochloride
11/30/2000WO2000071107A2 New pharmaceutical combinations for nos inhibitors
11/30/2000WO2000047559A3 5-ht1f agonists
11/30/2000WO2000042989A3 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
11/30/2000WO2000032583A9 Antitumor dibenzofluorene derivatives
11/30/2000CA2374788A1 Inhibitors of factor xa
11/30/2000CA2374668A1 New pharmaceutical combinations for nos inhibitors
11/30/2000CA2374225A1 Naphthalene ureas as glucose uptake enhancers
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2372887A1 Heterocyclic analgesic compounds and their use
11/30/2000CA2372580A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000CA2371904A1 Inhibitors of factor xa
11/29/2000EP1055668A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/29/2000EP1054861A1 Cytostatic agents
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP0896539B1 Use of optically pure (+) norcisapride for treating emesis and central nervous system disorders
11/29/2000CN1274724A Prepn. of 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-asymmetric indacene
11/29/2000CN1274723A Dicyclic compound, medicine composition containing the same and use thereof
11/29/2000CN1274719A Process for preparation of substituted pyridine compound
11/29/2000CN1274711A New intermediate for preparation of anti-histamine piperidine derivatives
11/28/2000US6153755 Preparation of a 4-aryl-3-hydroxymethyl-piperidine by catalyzing the reduction of an isoxazolidine; making paroxetine
11/28/2000US6153754 Process for production of piperidine derivatives
11/28/2000US6153676 Piperidine hindered amine light stabilizers
11/28/2000US6153626 For treating pain, gastrointestinal disorders, spinal cord injury
11/28/2000US6153625 For treatment of disorders in which involvement of serotoninergic system has been demonstrated, as in psychiartic disorders such as depression, anxiety, panic attack, schizophrenia, aggression, impulsive disorders
11/28/2000US6153624 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders
11/28/2000US6153612 Sulfonamide inhibitors of matrix metalloproteinases
11/28/2000US6153611 As non-dopaminergic antiischemic compounds for treating brain disorders
11/28/2000US6153609 Arylsulfonylamino hydroxamic acid derivatives
11/28/2000US6153588 Stable non-hygroscopic crystalline form of N-[N-[N-4-(piperidin-4-yl)butanoyl)-N-ethylglycyl] aspartyl]-L-β-cyclohexyl alanine amide
11/28/2000US6153217 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
11/28/2000CA2309505A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2309475A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2309434A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2254506C Piperidine derivatives and process for their production
11/23/2000WO2000069822A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000WO2000069820A1 Cyclic amine derivatives and their uses
11/23/2000WO2000069819A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000WO2000069816A1 Metabotropic glutamate receptor antagonists
11/23/2000WO2000069815A1 Ureido-substituted cyclic amine derivatives and their use as drug
11/23/2000WO2000069811A1 Cyanobiphenyl derivatives
11/23/2000WO2000069810A1 Glucagon antagonists/inverse agonists
11/23/2000WO2000069432A1 Remedies or preventives for diseases in association with chemokines
11/23/2000WO2000034237A3 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
11/23/2000CA2373942A1 Remedies or prophylactis for diseases in association with chemokines
11/23/2000CA2373892A1 Glucagon antagonists/inverse agonists
11/23/2000CA2373607A1 Cyclic amine derivatives and their uses
11/23/2000CA2373500A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000CA2372934A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/22/2000EP1053238A1 Therapeutic compounds
11/22/2000EP1052992A1 Cyclic amine modulators of chemokine receptor activity
11/22/2000EP1052986A1 Anti-inflammatory agents
11/22/2000EP1052984A1 Antibacterial agents
11/22/2000EP0701443B2 Terfenadine metabolites and their optically pure isomers for treating allergic disorders
11/22/2000CN1274357A Antipsychotic substituted piperidine derivatives
11/22/2000CN1274288A Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
11/21/2000US6150527 Synthetic multimerizing agents
11/21/2000US6150526 Piperidine derivative having renin inhibiting activity
11/21/2000US6150397 5-aroylnaphthalene derivatives as anti-inflammatory agents
11/21/2000US6150378 Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
11/21/2000US6150367 1-(4-arylpiperazin-1-yl)-3-(2-oxopyrrolidin-1-yl )propane or 1-(4-arylpiperazin-1-yl)-3-(2-oxopiperidin-1-yl )propane can be used as therapeutic agents for hypertension, ischemia, and other cardiovascular disorders
11/21/2000US6150355 Phenylpiperidine derivative
11/21/2000US6149980 Perfluoroalkyl haloalkyl ethers and compositions and applications thereof
11/16/2000WO2000068186A1 Bis-sulfonamide with anti-hcmv effect
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
11/16/2000WO2000009103A3 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders
11/16/2000WO2000000157A3 Use of tempo and tempo derivatives for inducing cell death
11/15/2000CN1273581A Method and reagents for N-alkylating ureides
11/15/2000CN1273241A Hydroxy substituted N-alkoxy hindered amine
11/14/2000US6147253 N-protected/N-substituted-beta-amino-hydroxy sulfonates
11/14/2000US6147217 Synthesis of terfenadine and derivatives
11/14/2000US6147216 Intermediates useful for the preparation of antihistaminic piperidine derivatives
11/14/2000US6147215 Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof
11/14/2000US6147145 Vinyl monomers in which the vinyl bears a heteroatom selected from nitrogen, oxygen, sulfur and silicon and n-oxyl compound of a secondary amine which does not bear hydrogen on the alph-carbons to prevent premature polymerization
1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 380